Investigating how astrocyte signaling affects Fragile X Syndrome
The Role of Astrocyte BMP Signaling in Fragile X Syndrome
This study is looking at how certain brain cells called astrocytes might affect the symptoms of Fragile X Syndrome, which is a condition that can cause learning challenges and autism, to find new ways to help improve treatments for those with the condition.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10909263 on NIH RePORTER |
What this research studies
This research explores the role of astrocyte bone morphogenetic protein (BMP) signaling in Fragile X Syndrome (FXS), a common inherited cause of intellectual disability and autism. The study uses a mouse model to understand how changes in astrocytes, a type of brain cell, contribute to the symptoms of FXS. By examining the proteins secreted by these astrocytes, researchers aim to uncover new pathways that could lead to better treatments for FXS. The findings may help identify potential therapeutic targets that could improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Fragile X Syndrome or those who exhibit symptoms related to autism spectrum disorder.
Not a fit: Patients without a diagnosis of Fragile X Syndrome or related conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment strategies for Fragile X Syndrome that address the underlying causes rather than just the symptoms.
How similar studies have performed: Other research has shown promising results in targeting astrocyte functions in neurological disorders, suggesting that this approach may yield valuable insights for Fragile X Syndrome.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Deng, James Derong — University of California, San Diego
- Study coordinator: Deng, James Derong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.